This company is no longer active
BCAC Stock Overview
Brookline Capital Acquisition Corp. does not have significant operations. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Brookline Capital Acquisition Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$21.35 |
52 Week High | US$31.35 |
52 Week Low | US$9.50 |
Beta | 0 |
11 Month Change | 110.12% |
3 Month Change | 111.16% |
1 Year Change | 117.39% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 100.45% |
Recent News & Updates
Recent updates
Shareholder Returns
BCAC | US Capital Markets | US Market | |
---|---|---|---|
7D | 114.6% | 2.1% | 2.2% |
1Y | 117.4% | 55.8% | 32.6% |
Return vs Industry: BCAC exceeded the US Capital Markets industry which returned -15.4% over the past year.
Return vs Market: BCAC exceeded the US Market which returned -12.7% over the past year.
Price Volatility
BCAC volatility | |
---|---|
BCAC Average Weekly Movement | 36.0% |
Capital Markets Industry Average Movement | 3.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BCAC's share price has been volatile over the past 3 months.
Volatility Over Time: BCAC's weekly volatility has increased from 18% to 36% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | n/a | Sam Wertheimer | www.brooklinecapitalacquisitioncorp.com |
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector.
Brookline Capital Acquisition Corp. Fundamentals Summary
BCAC fundamental statistics | |
---|---|
Market cap | US$144.03m |
Earnings (TTM) | -US$2.77m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-52.0x
P/E RatioIs BCAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BCAC income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$2.77m |
Earnings | -US$2.77m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.41 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BCAC perform over the long term?
See historical performance and comparison